We propose that AS-IV attenuates PD-L1-mediated immune suppression in HCC through the miR-135b-5p/CNDP1 axis and elucidates the mechanism by which AS-IV acts in developing HCC. Here, CD274 is linked to hepatocellular carcinoma.